Activation of nuclear factor of activated T cells 5 in the peritoneal membrane of uremic patients

American Journal of Physiology - Renal Physiology

Volumn 308, Issue 11, 2015, Pages F1247-F1258

  Kitterer, Daniel ^a   Latus, Joerg ^a   Ulmer, Christoph ^a   Fritz, Peter ^a   Biegger, Dagmar ^b   Ott, German ^a   Alscher, M Dominik ^a   Witowski, Janusz ^c   Kawka, Edyta ^d   Jörres, Achim ^d   Seeger, Harald ^e,f   Segerer, Stephan ^e,f   Braun, Niko ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Chemokine (C C motif) ligand 2; Human peritoneal fibroblasts; Mesothelial cell; Monocyte chemoattractant protein 1; Nuclear factor of activated T cells 5

Indexed keywords

CHLORDANE; GLUCOSE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT5; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; CCL2 PROTEIN, HUMAN; CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFAT5 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; PERITONEAL BIOPSY; PERITONEAL FIBROSIS; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; UREMIA; AGED; CELL CULTURE; EPITHELIUM CELL; GENETICS; METABOLISM; MIDDLE AGED; PERITONEAL DIALYSIS; PHYSIOLOGY; PROCEDURES; TRANSCRIPTION INITIATION;

ADULT; AGED; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINES; EPITHELIAL CELLS; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; NF-KAPPA B; PERITONEAL DIALYSIS; PERITONEUM; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; UREMIA;

EID: 84930848242     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00617.2014     Document Type: Article

References (64)

1. Aguilera A, Yanez-Mo M, Selgas R, Sanchez-Madrid F, Lopez-Cabrera M. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients. Curr Opin Investig Drugs6: 262–268, 2005
2. Aramburu J, Drews-Elger K, Estrada-Gelonch A, Minguillon J, Morancho B, Santiago V, Lopez-Rodriguez C. Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5. Biochem Pharmacol72: 1597–1604, 2006
3. Beck FX, Neuhofer W. Cell volume regulation in the renal papilla. Contrib Nephrol152: 181–197, 2006
4. Bertoli SV, Barone MT, Vago L, Bonetto S, De Vecchi A, Scalamogna A, Barbiano di Belgiojoso G. Changes in peritoneal membrane after continuous ambulatory peritoneal dialysis–a histopathological study. Adv Perit Dial15: 28–31, 1999
5. Braun N, Alscher DM, Fritz P, Edenhofer I, Kimmel M, Gaspert A, Reimold F, Bode-Lesniewska B, Ziegler U, Biegger D, Wuthrich RP, Segerer S. Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis. Nephrol Dial Transplant26: 1033–1041, 2011
6. Braun N, Fritz P, Ulmer C, Latus J, Kimmel M, Biegger D, Ott G, Reimold F, Thon KP, Dippon J, Segerer S, Alscher MD. Histological criteria for encapsulating peritoneal sclerosis - a standardized approach. PLos One7: e48647, 2012
7. Braun N, Reimold F, Biegger D, Fritz P, Kimmel M, Ulmer C, Alscher MD. Fibrogenic growth factors in encapsulating peritoneal sclerosis. Nephron Clin Pract113: c88–95, 2009
8. Breborowicz A, Polubinska A, Oreopoulos DG. Changes in volume of peritoneal mesothelial cells exposed to osmotic stress. Perit Dial Int19: 119–123, 1999
9. Calhoun P. The osmolal gap in renal failure. Ann Intern Med99: 283, 1983
10. Chen YT, Chang YT, Pan SY, Chou YH, Chang FC, Yeh PY, Liu YH, Chiang WC, Chen YM, Wu KD, Tsai TJ, Duffield JS, Lin SL. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol25: 2847–2858, 2014
11. Cheung CY, Ko BC. NFAT5 in cellular adaptation to hypertonic stress– regulations and functional significance. J Mol Signal8: 5, 2013
12. Cho Y, Johnson DW, Badve S, Craig JC, Strippoli GF, Wiggins KJ. Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials. Nephrol Dial Transplant28: 1899–1907, 2013
13. Cho Y, Johnson DW, Badve SV, Craig JC, Strippoli GF, Wiggins KJ. The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int84: 969–979, 2013
14. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9: 1285–1292, 1998
15. Cohen CD, Frach K, Schlondorff D, Kretzler M. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int61: 133–140, 2002
16. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant11: 498–506, 1996
17. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int54: 2207–2217, 1998
18. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res29: 313–326, 2009
19. Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P, Bernini M, Pucci AM, Ibba L, Sabatelli P, et al. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron44: 204–211, 1986
20. Dimitriadis A, Antoniou S, Toliou T, Papadopoulos C. Tissue reaction to deep cuff of Tenckhoff’s catheter and peritonitis. Adv Perit Dial6: 155–158, 1990
21. Distler JH, Akhmetshina A, Schett G, Distler O. Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis. Rheumatology (Oxford)48: 98–103, 2009
22. Dursun H, Noyan A, Cengiz N, Attila G, Buyukcelik M, Soran M, Seydaoglu G, Bayazit AK, Anarat A. Changes in osmolal gap and osmolality in children with chronic and end-stage renal failure. Nephron Physiol105: p19–p21, 2007
23. Ferraris JD, Williams CK, Persaud P, Zhang Z, Chen Y, Burg MB. Activity of the TonEBP/OREBP transactivation domain varies directly with extracellular NaCl concentration. Proc Natl Acad Sci USA99: 739–744, 2002
24. Forst SA, Roberts DL. Signal transduction by the EnvZ-OmpR phosphotransfer system in bacteria. Res Microbiol145: 363–373, 1994
25. Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem271: 17779–17784, 1996
26. Go WY, Liu X, Roti MA, Liu F, Ho SN. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc Natl Acad Sci USA101: 10673–10678, 2004
27. Ha H, Yu MR, Choi HN, Cha MK, Kang HS, Kim MH, Lee HB. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Perit Dial Int 20, Suppl5: S10–S18, 2000
28. Halterman JA, Kwon HM, Wamhoff BR. Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5). Am J Physiol Cell Physiol302: C1–C8, 2012
29. Haslinger B, Mandl-Weber S, Sellmayer A, Lederer SR, Sitter T. Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: involvement of protein kinase C. Nephron87: 346–351, 2001
30. Higuchi C, Nishimura H, Sanaka T. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis. Ther Apher Dial10: 372–379, 2006
31. Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, Hirano H. Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol3: 720–728, 2008
32. Honda K, Nitta K, Horita S, Yumura W, Nihei H. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron72: 171–176, 1996
33. Jimenez-Heffernan JA, Aguilera A, Aroeira LS, Lara-Pezzi E, Bajo MA, del Peso G, Ramirez M, Gamallo C, Sanchez-Tomero JA, Alvarez V, Lopez-Cabrera M, Selgas R. Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch444: 247–256, 2004
34. Kino T, Segars JH, Chrousos GP. The guanine nucleotide exchange factor Brx: a link between osmotic stress, inflammation and organ physiology and pathophysiology. Expert Rev Endocrinol Metab5: 603–614, 2010
35. Kino T, Takatori H, Manoli I, Wang Y, Tiulpakov A, Blackman MR, Su YA, Chrousos GP, DeCherney AH, Segars JH. Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal2: ra5, 2009
36. Kuper C, Beck FX, Neuhofer W. NFAT5 contributes to osmolalityinduced MCP-1 expression in mesothelial cells. Mediators Inflamm2012: 513015, 2012
37. Kuper C, Steinert D, Fraek ML, Beck FX, Neuhofer W. EGF receptor signaling is involved in expression of osmoprotective TonEBP target gene aldose reductase under hypertonic conditions. Am J Physiol Renal Physiol296: F1100–F1108, 2009
38. Lee SD, Woo SK, Kwon HM. Dimerization is required for phosphorylation and DNA binding of TonEBP/NFAT5. Biochem Biophys Res Commun294: 968–975, 2002
39. Lee SH, Kang HY, Kim KS, Nam BY, Paeng J, Kim S, Li JJ, Park JT, Kim DK, Han SH, Yoo TH, Kang SW. The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells. Lab Invest92: 1698–1711, 2012
40. Lee SK, Kim BS, Yang WS, Kim SB, Park SK, Park JS. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. Kidney Int60: 55–64, 2001
41. Loureiro J, Aguilera A, Selgas R, Sandoval P, Albar-Vizcaino P, Perez-Lozano ML, Ruiz-Carpio V, Majano PL, Lamas S, Rodriguez- Pascual F, Borras-Cuesta F, Dotor J, Lopez-Cabrera M. Blocking TGF-b1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol22: 1682–1695, 2011
42. Margetts PJ, Hoff C, Liu L, Korstanje R, Walkin L, Summers A, Herrick S, Brenchley P. Transforming growth factor _-induced peritoneal fibrosis is mouse strain dependent. Nephrol Dial Transplant28: 2015–2027, 2013
43. Matsuo H, Tamura M, Kabashima N, Serino R, Tokunaga M, Shibata T, Matsumoto M, Aijima M, Oikawa S, Anai H, Nakashima Y. Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-kB in peritoneal mesothelial cells. Kidney Int69: 736–746, 2006
44. Neuhofer W. Role of NFAT5 in inflammatory disorders associated with osmotic stress. Curr Genomics11: 584–590, 2010
45. Neuhofer W, Bartels H, Fraek ML, Beck FX. Relationship between intracellular ionic strength and expression of tonicity-responsive genes in rat papillary collecting duct cells. J Physiol543: 147–153, 2002
46. Neuhofer W, Woo SK, Na KY, Grunbein R, Park WK, Nahm O, Beck FX, Kwon HM. Regulation of TonEBP transcriptional activator in MDCK cells following changes in ambient tonicity. Am J Physiol Cell Physiol283: C1604–C1611, 2002
47. Neusser MA, Kraus AK, Regele H, Cohen CD, Fehr T, Kerjaschki D, Wuthrich RP, Penfold ME, Schall T, Segerer S. The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection. Kidney Int77: 801–808, 2010
48. Okada M, Matsumori A, Ono K, Furukawa Y, Shioi T, Iwasaki A, Matsushima K, Sasayama S. Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol18: 894–901, 1998
49. Park J, Ryu DR, Li JJ, Jung DS, Kwak SJ, Lee SH, Yoo TH, Han SH, Lee JE, Kim DK, Moon SJ, Kim K, Han DS, Kang SW. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells. Am J Physiol Renal Physiol295: F749–F757, 2008
50. Raitt DC, Posas F, Saito H. Yeast Cdc42 GTPase and Ste20 PAK-like kinase regulate Sho1-dependent activation of the Hog1 MAPK pathway. EMBO J19: 4623–4631, 2000
51. Roth I, Leroy V, Kwon HM, Martin PY, Feraille E, Hasler U. Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity. Mol Biol Cell21: 3459–3474, 2010
52. Schneider A, Panzer U, Zahner G, Wenzel U, Wolf G, Thaiss F, Helmchen U, Stahl RA. Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-_. Kidney Int56: 135–144, 1999
53. Selgas R, Bajo A, Jimenez-Heffernan JA, Sanchez-Tomero JA, Del Peso G, Aguilera A, Lopez-Cabrera M. Epithelial-to-mesenchymal transition of the mesothelial cell–its role in the response of the peritoneum to dialysis. Nephrol Dial Transplant 21, Suppl 2: ii2–ii7, 2006
54. Shaikh G, Sehgal R, Sandhu S, Vaddineni S, Fogel J, Rubinstein S. Changes in osmol gap in chronic kidney disease: an exploratory study. Ren Fail36: 198–201, 2014
55. Shimaoka T, Hamada C, Kaneko K, Io H, Sekiguchi Y, Aruga S, Inuma J, Inami Y, Hotta Y, Horikoshi S, Kumasaka T, Tomino Y. Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patients. Nephrol Dial Transplant25: 3379–3385, 2010
56. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol13: 470–479, 2002
57. Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl: S158–S161, 2003
58. Witowski J, Bender TO, Gahl GM, Frei U, Jorres A. Glucose degradation products and peritoneal membrane function. Perit Dial Int21: 201–205, 2001
59. Witowski J, Bender TO, Wisniewska-Elnur J, Ksiazek K, Passlick- Deetjen J, Breborowicz A, Jorres A. Mesothelial toxicity of peritonea dialysis fluids is related primarily to glucose degradation products, not to glucose per se. Perit Dial Int23: 381–390, 2003
60. Witowski J, Jorres A. Peritoneal cell culture: fibroblasts. Perit Dial Int26: 292–299, 2006
61. Wolf G, Jocks T, Zahner G, Panzer U, Stahl RA. Existence of a regulatory loop between MCP-1 and TGF-b in glomerular immune injury. Am J Physiol Renal Physiol283: F1075–F1084, 2002
62. Zareie M, van Lambalgen AA, ter Wee PM, Hekking LH, Keuning ED, Schadee-Eestermans IL, Faict D, Degreve B, Tangelder GJ, Beelen RH, van den Born J. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid. Perit Dial Int25: 58–67, 2005
63. Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT. Growth factors VEGF and TGF-b1 in peritoneal dialysis. J Lab Clin Med134: 124–132, 1999
64. Zweers MM, Struijk DG, Smit W, Krediet RT. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up. J Lab Clin Med137: 125–132, 2001